Knockdown resistance (kdr) associated organochlorine resistance in mosquito-borne diseases (Culex quinquefasciatus): Systematic study of reviews and meta-analysis
PLOS Neglected Tropical Diseases · 19.08.2024 · 18 (8) · e0011991
DOI: 10.1371/journal.pntd.0011991 ↗Kurz gefasst
Metaanalyse in der Zeitschrift PLOS Neglected Tropical Diseases, online erschienen am 19.08.2024. Verfasst von Ebrahim Abbasi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Research Center for Health Sciences, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran. Hauptthemen laut MEDLINE: Culex, Insecticide Resistance, Insecticides, Mosquito Vectors. Die Arbeit wurde bisher 67-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Culex quinquefasciatus is one of the most important carriers of human pathogens. Using the insecticides is one of the most important methods of combating this vector. But the genetic resistance created in Culex quinquefasciatus led to disruption in the fight against this pest. Consequently, it is necessary to know the level of resistance to fight this vector. Based on this, the present study was conducted to investigate the prevalence of kdr resistance in Culex quinquefasciatus against organochlorine insecticides in the world.
Methods
This study was conducted by systematic review, and meta-analysis on the prevalence of kdr resistance and mortality rate in Culex quinquefasciatus against organochlorine insecticides in the world. All pertinent articles were extracted and analyzed in accordance with this information during an unrestricted search of the scientific databases Web of Science, PubMed, Scopus, biooan.org , Embase, ProQuest, and Google Scholar until the end of November 2023. Statistical analysis of data was done using fixed and random effects model in meta-analysis, I 2 index, Cochran’s test, and meta-regression by STATA version 17 software.
Results
Seventy articles were included in the meta-analysis process. Based on the findings, the prevalence of Kdr in Culex quinquefasciatus against organochlorine insecticide was estimated at 63.1%. Moreover, the mortality rate against the insecticide deltamethrin was 46%, DDT 18.5%, permethrin 42.6%, malathion 54.4% and lambdacyhalothrin 53%.
Conclusion
More than half of Cx. quinquefasciatus had Kdr . This vector was relatively resistant to DDT and permethrin insecticides and sensitive to malathion, deltamethrin and lambdacyhalothrin. In order to prevent the development of resistance to alternative insecticides, it is consequently critical to combat this vector with efficacious insecticides.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Research Center for Health Sciences, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
- Department of Biology and Control of Disease Vectors, School of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
- Health Deputy, Shiraz University of Medical Sciences, Shiraz, Iran.
ORCID-Profile: Ebrahim Abbasi
Zitieren
APA
Abbasi, E., & Daliri, S. (2024). Knockdown resistance (kdr) associated organochlorine resistance in mosquito-borne diseases (Culex quinquefasciatus): Systematic study of reviews and meta-analysis. PLOS Neglected Tropical Diseases, 18(8), e0011991. https://doi.org/10.1371/journal.pntd.0011991
Vancouver
Abbasi E, Daliri S. Knockdown resistance (kdr) associated organochlorine resistance in mosquito-borne diseases (Culex quinquefasciatus): Systematic study of reviews and meta-analysis. PLOS Neglected Tropical Diseases. 2024;18(8):e0011991. doi:10.1371/journal.pntd.0011991
BibTeX
@article{Abbasi2024,
author = {Abbasi, Ebrahim and Daliri, Salman},
title = {Knockdown resistance (kdr) associated organochlorine resistance in mosquito-borne diseases (Culex quinquefasciatus): Systematic study of reviews and meta-analysis},
journal = {PLOS Neglected Tropical Diseases},
year = {2024},
volume = {18},
number = {8},
pages = {e0011991},
doi = {10.1371/journal.pntd.0011991}
}
EUVIMED